YXX-24139-94372
3 vaccinations
5 coded responses
17 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 030 / NH
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
-
2021-01-28
Dose 2 — Moderna
- 2021-01-28
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-11
-
2021-02-18
Survey response — day 21, dose 2MedDRA: Back pain, Headache, Ophthalmic migraine — Feeling: FairFree text: Ocular migraine Back pain HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
-
2021-03-04
Survey response — day 35, dose 2MedDRA: Back pain, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headache back painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
-
2021-04-29
Survey response — 3 months, dose 2MedDRA: Muscle spasms — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Muscle spasmsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-02
-
2022-01-28
Survey response — 12 months, dose 2MedDRA: Oropharyngeal pain — Feeling: FairFree text: Soar throatMedDRA releases: 2024-11 · check-in free text available
-
2022-02-22
Dose 3 — Moderna
- 2022-04-11
-
2022-05-27
Survey response — 3 months, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
-
2022-05-27
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-28 | Moderna | |
| 3 | 2022-02-22 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-29 | Unsuccessful | |
| 2022-05-27 | Unsuccessful |
Free text
Release 4 — day 21, dose 2
Symptoms: Ocular migraine Back pain Headaches
Release 5 — day 35, dose 2
Symptoms: Headache back pain
Release 8 — 3 months, dose 2
Symptoms: Muscle spasms
Release 11 — 12 months, dose 2
Symptoms: Soar throat
Release 11 — 3 months, dose 3
Symptoms: Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Ophthalmic migraine | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release